Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00184964
Other study ID # 2004/032
Secondary ID
Status Recruiting
Phase N/A
First received September 12, 2005
Last updated June 3, 2008
Start date June 2004

Study information

Verified date June 2008
Source Radboud University
Contact Dominic A Schinagl, MD
Phone +31243614515
Email d.schinagl@rther.umcn.nl
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Interventional

Clinical Trial Summary

CT-PET image fusion has the potential to differentiate 'tumor' from 'atelectasis' much better than the CT-scan in patients with non-small cell lung cancer who also have atelectasis.

This however has never been validated on a histological level. In this study patients with non small cell lung cancer and atelectasis who are eligible for surgery undergo a CT-scan and a PET-scan prior to surgery.

The resection specimen will be compared to the preoperative imaging.


Recruitment information / eligibility

Status Recruiting
Enrollment 15
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

-Patients with non small cell lung cancer and atelectasis, who are eligible for surgery.

Exclusion Criteria:

- age < 18 years

- pregnancy

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Procedure:
CT-scan, PET-scan


Locations

Country Name City State
Netherlands Radboud University Nijmegen Medical Centre Nijmegen Gelderland

Sponsors (1)

Lead Sponsor Collaborator
Radboud University

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Histological validation of CT-PET image fusion.
See also
  Status Clinical Trial Phase
Completed NCT02135211 - Healthy Directions After Lung Surgery Pilot N/A
Completed NCT00191230 - Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer Phase 2
Withdrawn NCT01004419 - Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer Phase 1
Completed NCT01671332 - Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer Phase 2
Terminated NCT00905801 - Computed Tomography (CT) Perfusion Imaging of Lung Cancer N/A
Completed NCT00191256 - Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer Phase 2
Completed NCT00954278 - Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer Phase 1
Terminated NCT01282151 - TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer Phase 3
Terminated NCT01088906 - Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC Phase 2
Completed NCT00553254 - Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer Phase 2
Completed NCT01469000 - A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC) Phase 2
Withdrawn NCT00934076 - Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer Phase 1
Completed NCT00798720 - Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer Phase 2
Terminated NCT01891669 - A Study Of PF-06263507 In Patients With Advanced Solid Tumors Phase 1
Completed NCT00160069 - Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer Phase 2
Completed NCT00548093 - PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib Phase 2